標(biāo)題: Titlebook: Chemotherapy Protocols and Infusion Sequence; Schedule Considerati Iago Dillion Lima Cavalcanti Book 2022 The Editor(s) (if applicable) and [打印本頁] 作者: rupture 時間: 2025-3-21 19:33
書目名稱Chemotherapy Protocols and Infusion Sequence影響因子(影響力)
書目名稱Chemotherapy Protocols and Infusion Sequence影響因子(影響力)學(xué)科排名
書目名稱Chemotherapy Protocols and Infusion Sequence網(wǎng)絡(luò)公開度
書目名稱Chemotherapy Protocols and Infusion Sequence網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Chemotherapy Protocols and Infusion Sequence被引頻次
書目名稱Chemotherapy Protocols and Infusion Sequence被引頻次學(xué)科排名
書目名稱Chemotherapy Protocols and Infusion Sequence年度引用
書目名稱Chemotherapy Protocols and Infusion Sequence年度引用學(xué)科排名
書目名稱Chemotherapy Protocols and Infusion Sequence讀者反饋
書目名稱Chemotherapy Protocols and Infusion Sequence讀者反饋學(xué)科排名
作者: AUGER 時間: 2025-3-21 21:09
https://doi.org/10.1007/978-3-642-11470-0ting the main drugs included in each anticancer therapy. In addition, I talk about combined therapy, which is based on the association of drugs with different mechanisms of action, promoting greater efficacy in cancer therapy, and I also highlight the main challenges of combined therapy, which shoul作者: metropolitan 時間: 2025-3-22 01:55 作者: 蓋他為秘密 時間: 2025-3-22 05:26
Quantum Quenching, Annealing and Computatione molecular subtype, and the main therapeutic modalities of breast cancer. I discuss several chemotherapy protocols used in the treatment of adjuvant breast cancer, such as the AC, ACT, CMF, FEC, DAC, TDC, and DCARBT protocols, among others. I also discuss the protocols indicated for the treatment o作者: Discrete 時間: 2025-3-22 08:55
S. Tanaka,M. Hirano,S. Miyashitaliary tract, gallbladder, liver, among others, addressing their epidemiological profiles, in addition to bringing some data about pathophysiology of each cancer. I also discuss the protocols used according to cancer of the gastrointestinal tract, bringing efficacy data for each protocol and their in作者: 征稅 時間: 2025-3-22 16:29 作者: 征稅 時間: 2025-3-22 20:49 作者: 只有 時間: 2025-3-22 23:32 作者: 無法破譯 時間: 2025-3-23 05:00 作者: 躲債 時間: 2025-3-23 06:36
https://doi.org/10.1007/978-3-031-10839-6Chemotherapy protocols; Polypharmacy; Genitourinary cancer protocols; Head and neck cancer protocols; Lu作者: condone 時間: 2025-3-23 09:43 作者: 雀斑 時間: 2025-3-23 13:53 作者: 協(xié)定 時間: 2025-3-23 21:02 作者: Brocas-Area 時間: 2025-3-24 01:11
Polypharmacy in Cancer Therapy,ent of patients with multimorbidities and its use in the treatment of cancer patients. I also discuss drug interactions that can occur in patients using polypharmacy, highlighting studies that bring data on drug interactions in cancer treatment, such as pharmacodynamic and pharmacokinetic interactio作者: Deject 時間: 2025-3-24 05:43
Combined Therapy for the Treatment of Cancer,ting the main drugs included in each anticancer therapy. In addition, I talk about combined therapy, which is based on the association of drugs with different mechanisms of action, promoting greater efficacy in cancer therapy, and I also highlight the main challenges of combined therapy, which shoul作者: 整潔 時間: 2025-3-24 09:23
Importance of the Infusion Order in the Treatment of Cancer, bring the classification of infusion types according to time, such as bolus infusion, rapid infusion and continuous infusion, and its purpose in the application of antineoplastic drugs. I discuss the differences between reconstitution and dilution of drugs, as well as their stability after reconsti作者: 孤獨(dú)無助 時間: 2025-3-24 14:08
Chemotherapeutic Protocols for the Treatment of Breast Cancer,e molecular subtype, and the main therapeutic modalities of breast cancer. I discuss several chemotherapy protocols used in the treatment of adjuvant breast cancer, such as the AC, ACT, CMF, FEC, DAC, TDC, and DCARBT protocols, among others. I also discuss the protocols indicated for the treatment o作者: 車床 時間: 2025-3-24 18:02
Chemotherapeutic Protocols for the Treatment of Gastrointestinal Tract Cancer,liary tract, gallbladder, liver, among others, addressing their epidemiological profiles, in addition to bringing some data about pathophysiology of each cancer. I also discuss the protocols used according to cancer of the gastrointestinal tract, bringing efficacy data for each protocol and their in作者: Basilar-Artery 時間: 2025-3-24 19:45 作者: Nucleate 時間: 2025-3-25 02:24
Chemotherapeutic Protocols for the Treatment of Gynecological Cancer,ss the epidemiological profile of each cancer and bring some data on the pathophysiology, staging, and treatment modalities. The main chemotherapy protocols are also addressed, such as CABR, CAPBEV, CISP, CAD, EMA-CO, DM, among others. Administration schedules were based on clinical studies and prot作者: Esophagitis 時間: 2025-3-25 06:21
Chemotherapeutic Protocols for the Treatment of Head and Neck Cancer,thophysiological data, staging, and the main therapeutic modalities. I also discuss some protocols indicated for the treatment of head and neck cancers, such as the FUP, EP, PG, PC, PCP, PFP, VNC protocols, and among others. Administration schedules were based on clinical studies and protocols avail作者: 少量 時間: 2025-3-25 08:02 作者: 爵士樂 時間: 2025-3-25 12:23 作者: BANAL 時間: 2025-3-25 19:37 作者: 伸展 時間: 2025-3-25 20:58
Chemotherapeutic Protocols for the Treatment of Lung Cancer,作者: Horizon 時間: 2025-3-26 04:03
Book 2022ed by type of cancer. The content is focused on solid tumors, dividing the chapters according to breast, gastrointestinal, genitourinary, gynecological, head and neck, lung, and neurological cancers. In each chapter the epidemiological profiles, pathophysiology, therapeutic modalities, and the main 作者: Benzodiazepines 時間: 2025-3-26 06:43 作者: Ophthalmoscope 時間: 2025-3-26 08:57
interactions in therapeutic combination.Facilitates the searThis book aims to address the infusion sequence of the main protocols used in the treatment of varied solid cancers. Since an inadequate infusion sequence can compromise the patient‘s treatment, this work will provide support to professiona作者: 不法行為 時間: 2025-3-26 16:36 作者: 自制 時間: 2025-3-26 20:03 作者: 勾引 時間: 2025-3-26 23:41 作者: Hla461 時間: 2025-3-27 01:24
Social Fields and Social Forcesocols available on hospital websites and in the 2017 chemotherapy protocol book. The low number of clinical studies evaluating the efficacy and toxicity of the protocols according to the infusion schedule limits the data and reinforces the need for studies aimed at evaluating the infusion sequence of chemotherapy protocols.作者: OMIT 時間: 2025-3-27 06:10 作者: ABYSS 時間: 2025-3-27 12:37
https://doi.org/10.1007/978-3-642-11015-3n of toxicity, and improvement in the quality of life of patients. Finally, I talk about the risks of polypharmacy, such as the increase in the development of adverse reactions due to drug interactions and can potentiate the toxic effects of drugs.作者: agenda 時間: 2025-3-27 13:38 作者: 追逐 時間: 2025-3-27 17:56 作者: SPURN 時間: 2025-3-28 02:00 作者: white-matter 時間: 2025-3-28 05:50 作者: THE 時間: 2025-3-28 06:41 作者: 靦腆 時間: 2025-3-28 11:02 作者: 音的強(qiáng)弱 時間: 2025-3-28 15:38 作者: menopause 時間: 2025-3-28 20:25
Book 2022ence can compromise the patient‘s treatment, this work will provide support to professionals working in the field of oncology in assessing each chemotherapy infusion sequence. The introductory chapters present the definition, indication, and the risks and benefits of polypharmacy in cancer therapy,作者: 側(cè)面左右 時間: 2025-3-29 00:30
Combined Therapy for the Treatment of Cancer,d be taken into account when choosing the best combination for the treatment of a particular cancer. Finally, I discuss the toxicity profiles of the treatment of various cancers, such as toxicity related to the treatment of breast, lung, colorectal, prostate, cervix, and head and neck cancers.作者: BLAZE 時間: 2025-3-29 03:25 作者: crease 時間: 2025-3-29 07:34
